Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Efficacy of A. Vogel Sore Throat Lozenges in Acute Sore Throats
NCT04139681Phase 4Completed
- Sponsor
- A.Vogel
- Start
- Mar 2019
- Primary completion
- Apr 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of echinacea purpurea extract and salvia officinalis in acute pharyngitis, acute tonsillitis and viral respiratory tract infection, sponsored by A.Vogel. Primary endpoint: Rate of 'good' and 'very good' tolerability ratings vs. 'moderate' and 'bad' tolerability ratings as assessment by a physician at 4 days. Started Mar 2019; status: completed.
02
Drugs
echinacea purpurea extractsalvia officinalis
03
Conditions
acute pharyngitisacute tonsillitisviral respiratory tract infection
Beyond the preview
Go deeper on NCT04139681.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04139681.